Skip to main content

CITADEL ADVISORS LLC

Position in DNA — Ginkgo Bioworks Holdings, Inc.

CIK 1423053 MIAMI, FL

Position in DNA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record

Common Shares in DNA Over Time

Shares Held

Position Value (USD)

Derivatives in DNA

reported options exposure · as of Mar 31, 2026
CallValue
$217,002
CallShares
35,400
PutValue
$326,729
PutShares
53,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in DNA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $326,729 53,300
2026-03-31 $217,002 35,400
2025-12-31 $595,245 71,630
2025-12-31 $1,138,470 137,000
2025-09-30 $652,280 44,738
2025-09-30 $2,979,393 204,348
2025-06-30 $133,852 11,898
2025-06-30 $5,005,170 444,904
2025-06-30 $113,782 10,114
2025-03-31 $393,835 69,094
2025-03-31 $543,289 95,314
2024-12-31 $1,276,285 129,968
2024-12-31 $1,391,837 141,735
2024-12-31 $586,862 59,762
2024-09-30 $510,825 62,678
2024-09-30 $487,370 59,800